Published in J Neuroinflammation on September 02, 2014
Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase. J Neuroinflammation (2016) 1.00
Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology. Neural Regen Res (2015) 0.89
Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep (2016) 0.87
Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice. J Neuroinflammation (2015) 0.80
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol (2016) 0.80
Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE). Int J Mol Sci (2015) 0.78
Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial. J Neuroinflammation (2015) 0.77
Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair. Biomed Res Int (2017) 0.76
Targeting inflammation to influence cognitive function following spinal cord injury: a randomized clinical trial. Spinal Cord (2016) 0.75
Systems Genomics Support for Immune and Inflammation Hypothesis of Depression. Curr Neuropharmacol (2016) 0.75
Study Protocol on Hormonal Mediation of Exercise on Cognition, Stress and Immunity (PRO-HMECSI): Effects of Different Exercise Programmes in Institutionalized Elders. Front Public Health (2016) 0.75
Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. Cell Death Dis (2017) 0.75
Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat (2017) 0.75
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 9.83
Mechanisms linking obesity with cardiovascular disease. Nature (2006) 9.07
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
The anti-inflammatory effect of exercise. J Appl Physiol (1985) (2005) 6.87
Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry (2004) 5.10
Hippocampal volume reduction in major depression. Am J Psychiatry (2000) 5.04
Exercise treatment for depression: efficacy and dose response. Am J Prev Med (2005) 4.99
Untreated depression and hippocampal volume loss. Am J Psychiatry (2003) 4.84
Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol (2000) 3.46
The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol (2005) 3.43
Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry (2008) 3.13
T cell apoptosis by tryptophan catabolism. Cell Death Differ (2002) 3.07
Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 3.00
Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 2.89
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry (2007) 2.89
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry (2002) 2.87
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett (1991) 2.61
Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A (1997) 2.50
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science (2005) 2.41
Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 2.36
Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J (2003) 2.31
T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med (1994) 2.31
Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev (2008) 2.30
The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology (2006) 2.12
Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med (2002) 2.12
Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology (2002) 2.11
Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm (2009) 2.09
Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem (1991) 2.01
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest (1996) 1.99
Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology (1999) 1.97
Major depression and activation of the inflammatory response system. Adv Exp Med Biol (1999) 1.84
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem (2001) 1.79
Exercise for depression. Cochrane Database Syst Rev (2012) 1.78
The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci (1998) 1.74
Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci (1995) 1.68
3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem (1998) 1.58
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther (1991) 1.57
TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. MedGenMed (2006) 1.56
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation (2011) 1.56
Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry (1998) 1.55
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience (2013) 1.55
Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology (2010) 1.51
Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology (1998) 1.51
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation (2008) 1.45
Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry (2007) 1.39
Elevations of endogenous kynurenic acid produce spatial working memory deficits. Schizophr Bull (2006) 1.38
Depression, stress and the adrenal axis. J Neuroendocrinol (2003) 1.32
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum. J Neurochem (2005) 1.31
Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci (2007) 1.30
The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl) (2003) 1.29
The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci (2009) 1.28
Cognitive impairment in the euthymic phase of affective disorder. Psychol Med (1998) 1.23
Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J Neurosci (2004) 1.23
Effect of physical activity on serum C-reactive protein. Am J Cardiol (2004) 1.22
Strenuous exercise: analogous to the acute-phase response? Clin Sci (Lond) (1991) 1.21
L-kynurenine: its synthesis and possible regulatory function in brain. Neurochem Res (1980) 1.21
Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release. Eur J Neurosci (2009) 1.20
Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci (2010) 1.18
Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells. J Interferon Cytokine Res (2006) 1.09
Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding. Behav Brain Res (2006) 1.09
Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J Neurochem (2008) 1.05
The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes. Biochem J (1985) 1.05
Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology (2002) 1.04
Urinary free cortisol excretion in depression. Psychol Med (1976) 1.04
Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol (1998) 1.01
Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. FEBS J (2009) 1.00
Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence. CNS Drugs (2009) 0.98
Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity: how low can you go? Arterioscler Thromb Vasc Biol (2003) 0.98
Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med (1992) 0.96
The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol (1995) 0.96
Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance. Diabetologia (2002) 0.96
Kynurenine and its metabolites in Alzheimer's disease patients. Adv Med Sci (2010) 0.94
Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med (2005) 0.93
Identification and characterization of novel variants of the tryptophan 2,3-dioxygenase gene: differential regulation in the mouse nervous system during development. Neurosci Res (2009) 0.93
Major depression during interferon-alpha treatment: vulnerability and prevention. Dialogues Clin Neurosci (2009) 0.92
Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun (2004) 0.92
The acute phase response and exercise: the ultramarathon as prototype exercise. Clin J Sport Med (2001) 0.88
Indicators of immune activation in depressed patients. Adv Exp Med Biol (1999) 0.87
Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism. Biochem Soc Trans (1985) 0.86
Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway. Free Radic Biol Med (2000) 0.84
Depressive breakthrough. Psychiatr Clin North Am (2000) 0.84
Effect of a tryptophan deficient diet on brain serotonin and plasma tryptophan level. Proc Soc Exp Biol Med (1963) 0.84
Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons. J Pharmacol Exp Ther (2004) 0.81
The effect of physical activity on cognition - physiological mechanisms. Mater Sociomed (2012) 0.81
Low-grade inflammation and spinal cord injury: exercise as therapy? Mediators Inflamm (2013) 0.79
Kynurenine concentration of serum was increased by exercise. Adv Exp Med Biol (1999) 0.77
Studies on the metabolism of 5-hydroxytryptamine (serotonin). II. Effect of tryptophan deficiency in rats. Proc Soc Exp Biol Med (1962) 0.76
Acute effects of physical exercise and phosphodiesterase's type 5 inhibition on serum 11β-hydroxysteroid dehydrogenases related glucocorticoids metabolites: a pilot study. Endocrine (2014) 0.75
Sexuality for women with spinal cord injury. J Sex Marital Ther (2014) 0.86
The effect of body weight-supported treadmill training on muscle morphology in an individual with chronic, motor-complete spinal cord injury: A case study. J Spinal Cord Med (2006) 0.80
A comparison of adductor pollicis fatigue in older men and women. Can J Physiol Pharmacol (2003) 0.80
Effects of autonomic blockade on nonlinear heart rate dynamics. Clin Auton Res (2010) 0.76